Flow cytometric analysis of Apoptosis and caspase activation inhibitor expression in HepG2 cells using Apoptosis and caspase activation inhibitor antibody (Cat#61818, 1:2,000). Fixative solution: 4% Paraformaldehyde in 1x PBS; Permeabilization solution: 0.5% Triton X-100 in 1x PBS. Green, isotype control; red, Apoptosis and caspase activation inhibitor.
Western blotting analysis using apoptosis and caspase activation inhibitor antibody (Cat#61818). Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with apoptosis and caspase activation inhibitor antibody (Cat#61818, 1:5,000) and HRP-conjugated goat anti-rabbit secondary antibody (Cat#201, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
Western blotting analysis using apoptosis and caspase activation inhibitor antibody (Cat#61818). Apoptosis and caspase activation inhibitor expression in wild-type (WT) and apoptosis and caspase activation inhibitor (AVEN) shRNA knockdown (KD) HT-1080 cells with 20 μg of total cell lysates. Hsp90 α serves as a loading control. The blot was incubated with apoptosis and caspase activation inhibitor antibody (Cat#61818, 1:5,000) and HRP-conjugated goat anti-rabbit secondary antibody (Cat#201, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
Immunocytochemical staining of HepG2 cells with Apoptosis and caspase activation inhibitor antibody (Cat#61818, 1:1,000). Nuclei were stained blue with DAPI; Apoptosis and caspase activation inhibitor was stained magenta with Alexa Fluor® 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Fixative solution: 4% Paraformaldehyde in 1x PBS; Permeabilization solution: 0.5% Triton X-100 in 1x PBS. Scale bar, 20 μm.
